National and Kapodistrian University of Athens
Προγνωστικοί δείκτες της βιολογικής συμπεριφοράς των νευροενδοκρινών όγκων του πνεύμονα: η σημασία της παρουσίας πεπτιδικών μεμβρανικών υποδοχέων
Abstract
dc:descriptionPulmonary carcinoids (PC) are among the most common neuroendocrine tumors. The current WHO classification (typical; TC and atypical carcinoids; AC) incorporates the concept of grading; however in a subgroup of tumors it may not predict adequately their biological behavior. Therefore, it is desirable to find prognostic markers which may predict the behavior of PCs complementarily and / or regardless of their morphology. Objective: the immunohistoche-mical study of the expression of IGF-1, its receptor IGF-1R, CTGF and HIF-1α in PCs and the evaluation of their role as prognostic markers in combination with Ki-67 proliferation index. In addition, the immunohistochemical mapping of the expression of the five somatostatin receptor subtypes (SSTR1-5) and dopamine receptor (DR2) in PCs as potential targets for molecular therapies. Retrospective study of 121 PCs (104 TC and 17 AC) from 110 patients. After multivariate analysis, only Ki-67 (cut off value: 3.4%), age at diagnosis and the presence of lymph node metastases were included in the prognostic model. In contrast, although all studied factors (IGF-1, IGF-1R, CTGF and HIF-1α) were expressed in the cytoplasm of the majority of tumors (78.5%, 67%, 72% and 78%, respectively), none of them were included in the logistic regression model. Their expression was more common in TC, although statistically significant only for HIF-1α (82% vs 53%, p = 0.023), which was also more often expressed in tumors ≤10mm. In contrast, CTGF was expressed in tumors> 10 mm (79% vs 50%, p = 0.007), or tumors accompanied by lymph node (90% vs 67%, p = 0.056) and distant metastases (89% vs. 65% = 0.044). Expression of IGF-1 and IGF-1R did not correlate significantly with any parameter. Detection of the above factors, mainly in small, well differentiated tumors, implies a role in early oncogenesis, whereas CTGF tends to be expressed in later stages of more extensive disease, possibly as a consequence of HIF-1α accumulation. Regarding receptors expression the results were: SSTR1 (63%), SSTR2A (72%), SSTR5 (40%) SSTR3 (20%), SSTR4 (0%) and DR2 (74%) and it was predominantly membranic for SSTR2A, whereas cytoplasmic for the rest. Co-expression of DR2 was mainly observed along with SSTR1 and SSTR2A (56% and 63%). The results of SSTR2A were confirmed with Octreoscan (90% agreement - k = 0.62), while membranic expression was associated with higher uptake. In a subgroup of 20 tumors, m-RNA of the receptors was searched with semi-quantitative RT-PCR and the concordance with the immunohistochemistry results was satisfactory at least regarding SSTR2A, SSTR3, SSTR4 and DR2. Receptor expression did not correlate with tumor aggressiveness or functionality, whereas DR2 was most commonly detected in ACs. By demonstrating a high degree of expression of SSTRs and DR2 in a significant number of tumors, we may provide a reasonable basis for the potential treatment of PCs with agents targeting these receptors.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kanakis, Georgios
- Κανάκης, Γεώργιος
Subjects
dc:subject × 14- Υποδοχείς σωματοστατίνης
- Υποδοχείς ντοπαμίνης
- Καρκινοειδές πνεύμονα
- Δείκτης κυτταρικού πολλαπλασιασμού Ki-67
- Αυξητικός παράγοντας συνδετικού ιστού (CTGF)
- Somatostatin receptor subtypes
- Dopamine receptors
- Ki-67 cell proliferation index
- Lung carcinoid
- Connective tissue growth factor (CTGF)
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42968